These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 25951989)

  • 1. A multi-targeted approach to suppress tumor-promoting inflammation.
    Samadi AK; Bilsland A; Georgakilas AG; Amedei A; Amin A; Bishayee A; Azmi AS; Lokeshwar BL; Grue B; Panis C; Boosani CS; Poudyal D; Stafforini DM; Bhakta D; Niccolai E; Guha G; Vasantha Rupasinghe HP; Fujii H; Honoki K; Mehta K; Aquilano K; Lowe L; Hofseth LJ; Ricciardiello L; Ciriolo MR; Singh N; Whelan RL; Chaturvedi R; Ashraf SS; Shantha Kumara HMC; Nowsheen S; Mohammed SI; Keith WN; Helferich WG; Yang X
    Semin Cancer Biol; 2015 Dec; 35 Suppl():S151-S184. PubMed ID: 25951989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing a broad-spectrum integrative approach for cancer prevention and treatment.
    Block KI; Gyllenhaal C; Lowe L; Amedei A; Amin ARMR; Amin A; Aquilano K; Arbiser J; Arreola A; Arzumanyan A; Ashraf SS; Azmi AS; Benencia F; Bhakta D; Bilsland A; Bishayee A; Blain SW; Block PB; Boosani CS; Carey TE; Carnero A; Carotenuto M; Casey SC; Chakrabarti M; Chaturvedi R; Chen GZ; Chen H; Chen S; Chen YC; Choi BK; Ciriolo MR; Coley HM; Collins AR; Connell M; Crawford S; Curran CS; Dabrosin C; Damia G; Dasgupta S; DeBerardinis RJ; Decker WK; Dhawan P; Diehl AME; Dong JT; Dou QP; Drew JE; Elkord E; El-Rayes B; Feitelson MA; Felsher DW; Ferguson LR; Fimognari C; Firestone GL; Frezza C; Fujii H; Fuster MM; Generali D; Georgakilas AG; Gieseler F; Gilbertson M; Green MF; Grue B; Guha G; Halicka D; Helferich WG; Heneberg P; Hentosh P; Hirschey MD; Hofseth LJ; Holcombe RF; Honoki K; Hsu HY; Huang GS; Jensen LD; Jiang WG; Jones LW; Karpowicz PA; Keith WN; Kerkar SP; Khan GN; Khatami M; Ko YH; Kucuk O; Kulathinal RJ; Kumar NB; Kwon BS; Le A; Lea MA; Lee HY; Lichtor T; Lin LT; Locasale JW; Lokeshwar BL; Longo VD; Lyssiotis CA; MacKenzie KL; Malhotra M; Marino M; Martinez-Chantar ML; Matheu A; Maxwell C; McDonnell E; Meeker AK; Mehrmohamadi M; Mehta K; Michelotti GA; Mohammad RM; Mohammed SI; Morre DJ; Muralidhar V; Muqbil I; Murphy MP; Nagaraju GP; Nahta R; Niccolai E; Nowsheen S; Panis C; Pantano F; Parslow VR; Pawelec G; Pedersen PL; Poore B; Poudyal D; Prakash S; Prince M; Raffaghello L; Rathmell JC; Rathmell WK; Ray SK; Reichrath J; Rezazadeh S; Ribatti D; Ricciardiello L; Robey RB; Rodier F; Rupasinghe HPV; Russo GL; Ryan EP; Samadi AK; Sanchez-Garcia I; Sanders AJ; Santini D; Sarkar M; Sasada T; Saxena NK; Shackelford RE; Shantha Kumara HMC; Sharma D; Shin DM; Sidransky D; Siegelin MD; Signori E; Singh N; Sivanand S; Sliva D; Smythe C; Spagnuolo C; Stafforini DM; Stagg J; Subbarayan PR; Sundin T; Talib WH; Thompson SK; Tran PT; Ungefroren H; Vander Heiden MG; Venkateswaran V; Vinay DS; Vlachostergios PJ; Wang Z; Wellen KE; Whelan RL; Yang ES; Yang H; Yang X; Yaswen P; Yedjou C; Yin X; Zhu J; Zollo M
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S276-S304. PubMed ID: 26590477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.
    Feitelson MA; Arzumanyan A; Kulathinal RJ; Blain SW; Holcombe RF; Mahajna J; Marino M; Martinez-Chantar ML; Nawroth R; Sanchez-Garcia I; Sharma D; Saxena NK; Singh N; Vlachostergios PJ; Guo S; Honoki K; Fujii H; Georgakilas AG; Bilsland A; Amedei A; Niccolai E; Amin A; Ashraf SS; Boosani CS; Guha G; Ciriolo MR; Aquilano K; Chen S; Mohammed SI; Azmi AS; Bhakta D; Halicka D; Keith WN; Nowsheen S
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S25-S54. PubMed ID: 25892662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the Cause and Consequence of Tumor Heterogeneity.
    Khatib S; Pomyen Y; Dang H; Wang XW
    Trends Cancer; 2020 Apr; 6(4):267-271. PubMed ID: 32209440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular pathways and therapeutic targets in lung cancer.
    Shtivelman E; Hensing T; Simon GR; Dennis PA; Otterson GA; Bueno R; Salgia R
    Oncotarget; 2014 Mar; 5(6):1392-433. PubMed ID: 24722523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy-associated targeting pathways of natural products during cancer treatment.
    Zhang SF; Wang XL; Yang XQ; Chen N
    Asian Pac J Cancer Prev; 2014; 15(24):10557-63. PubMed ID: 25605139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT proteins as novel targets for cancer drug discovery.
    Turkson J
    Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the mTOR pathway in tumor malignancy.
    Cheng H; Walls M; Baxi SM; Yin MJ
    Curr Cancer Drug Targets; 2013 Mar; 13(3):267-77. PubMed ID: 23297825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad targeting of resistance to apoptosis in cancer.
    Mohammad RM; Muqbil I; Lowe L; Yedjou C; Hsu HY; Lin LT; Siegelin MD; Fimognari C; Kumar NB; Dou QP; Yang H; Samadi AK; Russo GL; Spagnuolo C; Ray SK; Chakrabarti M; Morre JD; Coley HM; Honoki K; Fujii H; Georgakilas AG; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich WG; Yang X; Boosani CS; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Mohammed SI; Keith WN; Bilsland A; Halicka D; Nowsheen S; Azmi AS
    Semin Cancer Biol; 2015 Dec; 35 Suppl(0):S78-S103. PubMed ID: 25936818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.
    Surh YJ; Chun KS; Cha HH; Han SS; Keum YS; Park KK; Lee SS
    Mutat Res; 2001 Sep; 480-481():243-68. PubMed ID: 11506818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
    Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
    Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad targeting of angiogenesis for cancer prevention and therapy.
    Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
    Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
    Hua H; Kong Q; Yin J; Zhang J; Jiang Y
    J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality.
    Parameswaran S; Kundapur D; Vizeacoumar FS; Freywald A; Uppalapati M; Vizeacoumar FJ
    Trends Cancer; 2019 Jan; 5(1):11-29. PubMed ID: 30616753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor as a therapeutic target in glioblastoma.
    Kalman B; Szep E; Garzuly F; Post DE
    Neuromolecular Med; 2013 Jun; 15(2):420-34. PubMed ID: 23575987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory Process and Molecular Targets for Antiinflammatory Nutraceuticals.
    Huang MT; Ghai G; Ho CT
    Compr Rev Food Sci Food Saf; 2004 Oct; 3(4):127-139. PubMed ID: 33430565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.
    Chan MM; Chen R; Fong D
    Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of chromatin: status and opportunities.
    Siklos M; Kubicek S
    FEBS J; 2022 Mar; 289(5):1276-1301. PubMed ID: 33982887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.